Search bioRxiv⌕ Search

Biology subjects

Marangoni, F.

Publications and source records attributed to Marangoni, F..

2 recordsLinked to original sources

Classification of human actin pathological variants using C. elegans CRISPR-generated models

Actin plays a crucial role in diverse physiological processes by forming dynamic networks that determine cellular shape and mechanical properties. Non-Muscle Actinopathies (NMA) are rare diseases caused by de novo variants in human cytoskeletal {beta}-actin (ACTB) and {gamma}-actin (ACTG1) genes, ranging from missense mutations to whole gene deletions. Currently, the high clinical variability and genotype-phenotype correlations in NMA remain largely unresolved. To address this concern, we inserted nine mutations identified in patients in the C. elegans cytoplasmic actin orthologue act-2 and performed a quantitative multiscale characterization of these animal models. We uncovered various perturbations including micro-scale actin network defects, cell-scale abnormalities, morphogenesis failure, and weaker behavioural phenotypes. Notably, the severity of the observed defects correlates with the severity of patients symptoms. Thus, we provide evidence that such C. elegans models are relevant to investigate the mechanisms underlying NMA physiopathology and could ultimately be used to screen for therapeutic strategies.

cell biology↗

Interruption of the Intratumor CD8:Treg Crosstalk Improves the Efficacy of PD-1 Immunotherapy

PD-1 blockade unleashes the potent antitumor activity of CD8 cells but can also promote immunosuppressive T regulatory (Treg) cells, which may worsen response to immunotherapy. Tumor Treg inhibition is a promising strategy to overcome therapeutic resistance; however, the mechanisms supporting tumor Tregs during PD-1 immunotherapy are largely unexplored. Here, we report that PD-1 blockade increases tumor Tregs in mouse models of immunogenic tumors, including melanoma, and metastatic melanoma patients. Unexpectedly, Treg accumulation was not caused by Treg-intrinsic inhibition of PD-1 signaling but instead depended on an indirect effect of activated CD8 cells. CD8 cells colocalized with Tregs within tumors and produced IL-2, especially after PD-1 immunotherapy. IL-2 upregulated the anti-apoptotic protein ICOS on tumor Tregs, causing their accumulation. ICOS signaling inhibition before PD-1 immunotherapy resulted in increased control of immunogenic melanoma. Thus, interrupting the intratumor CD8:Treg crosstalk is a novel strategy that may enhance the efficacy of immunotherapy in patients.

immunology↗